Lv11
36 积分 2020-12-06 加入
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update
2小时前
待确认
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party
4小时前
已完结
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT
9天前
已完结
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT
18天前
已完结
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
1个月前
已完结
Single-cell immune landscape of measurable residual disease in acute myeloid leukemia
1个月前
已完结
Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40–50: a retrospective analysis from the CBMTR over the past decade
2个月前
已完结
Long-term survival in patients with Philadelphia-chromosome-positive acute lymphoblastic leukemia who relapse after allogeneic hematopoietic stem cell transplantation: a single-center experience
2个月前
已完结
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma
2个月前
已完结
Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis
3个月前
已完结
皖公网安备34019202002308
